CLEEVELANDS MEDICAL CENTRE
SAPPHIRE ROAD, BISHOPS CLEEVE, CHELTENHAM
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 15 | 18 | 83.3% | |
| HF 4 | 2011 | 14 | 17 | 82.4% | |
| HF 4 | 2012 | 17 | 20 | 85.0% | |
| HF 4 | 2013 | 30 | 32 | 93.8% | |
| HF004 | 2014 | 36 | 38 | 94.7% | |
| HF004 | 2015 | 36 | 36 | 100.0% | |
| HF004 | 2016 | 36 | 38 | 94.7% | |
| HF004 | 2017 | 55 | 57 | 96.5% | |
| HF004 | 2018 | 54 | 55 | 98.2% | |
| HF004 | 2019 | 50 | 52 | 96.2% | |
| HF004 | 2020 | 45 | 46 | 97.8% | |
| HF006 | 2021 | 51 | 55 | 92.7% | |
| HF006 | 2022 | 53 | 54 | 98.1% | |
| HF006 | 2023 | 61 | 63 | 96.8% |
